4
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor, We read with interest the paper written by Lechien et al. [1] describing a multi-centre cohort of COVID-19 patients, in which 85.6% had olfactory or taste disorders (OTD). If the association between COVID-19 and OTD is not recognized, the diagnosis may be missed. However, while a large proportion of COVID-19 patients had OTD, [1–3] the actual specificity as a criterion for screening suspected COVID-19 cases is unknown, as other viral infections may also cause OTD. Other studies have reported patients presenting with acute anosmia with or without upper respiratory tract symptoms, [4, 5] but not all patients were tested for COVID-19 [4]. Additionally, information on OTD in Asian cohorts is lacking [1]. In Singapore, the first case of COVID-19 was reported in end-January 2020. At our institution, the largest acute hospital in Singapore, from end-March 2020 all new admissions were screened for self-reported OTD at emergency department (ED) triage. All patients reporting new-onset OTD were admitted to exclude COVID-19. We report our experience using self-reported OTD as a screening criterion for suspected COVID-19. Over a 2-week period from 26 March–10 April 2020, given ongoing community transmission and the difficulty in distinguishing COVID-19 from ordinary viral infection, a questionnaire including respiratory symptoms, self-reported OTD, and travel and epidemiological risk factors was administered at ED triage to risk-stratify admissions. Suspect case criteria for COVID-19 were defined as the presence of respiratory symptoms and suspicious epidemiological links or travel history; or new-onset OTD. Testing was not limited to hospitalised inpatients; as part of the national strategy of containment, all patients who fulfilled suspect case criteria for COVID-19 were tested via real-time reverse transcription PCR (rRT-PCR) of oropharyngeal swabs, even if hospitalization was not otherwise required. Inpatient, if patients had respiratory symptoms and a viral prodrome, or OTD, oropharyngeal specimens were also tested for a routine panel of respiratory viruses. As this study was based on aggregated surveillance data, ethics approval was not required under our hospital’s Institutional Review Board guidelines. Over the study period, a total of 870 patients fulfilled suspect case criteria for COVID-19 at ED triage. A minority (5.05%, 44/870) presented with OTD. The majority of suspects (65.3%, 568/870) were well and discharged to self-isolate while awaiting results. Amongst suspected COVID-19 cases, 154 patients (17.9%, 154/870) tested positive. Of those, roughly one-fifth (22.7%, 35/154) had OTD. The presence of OTD had high specificity as a screening criterion for COVID-19 (98.7%, 95% CI 97.6–99.4%), but lower sensitivity (22.7%, 95% CI 16.4–30.2%). This was roughly equivalent to the specificity and sensitivity of a history of close contact with a confirmed COVID-19 case (specificity: 94.8%, 95% CI 93.0–96.3%; sensitivity: 27.3%, 95% CI 20.4–35.0%), Supplementary Table 1. Amongst the 35 COVID-19 positives with concomitant OTDs, three presented with isolated anosmia without other symptoms. Fever was the most common concomitant symptom (21/35, 60.0%), followed by cough (10/35, 28.5%) and rhinorrhea (10/35, 28.5%). Over the same period, a total of 71 admitted inpatients tested positive for other respiratory viruses, of which the most common was rhinovirus (53.5%, 38/71); followed by influenza (21.1%, 15/71), adenoviruses (8.5%, 6/71), other coronaviruses (7.0%, 5/71). Only 2.8% (2/71) self-reported OTD (one rhinovirus, one human coronavirus 229E). Amongst patients with PCR-proven acute respiratory viral infections, those positive for COVID-19 had higher odds of OTD compared to those positive for other respiratory viruses (odds ratio, OR = 10.14, 95% CI 2.37–43.49, p < 0.001). In conclusion, self-reported OTD had high specificity as a screening criterion for COVID-19 in an Asian cohort. Patients with COVID-19 appeared to have higher odds of OTD compared to those positive for other respiratory viruses. Routine screening in patients with new-onset OTD can improve case detection during a COVID-19 outbreak. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 15 kb)

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study

          To the Editor—We read with interest the article by Wang et al [1] describing the clinical features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China. The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection. After some patients admitted for coronavirus disease 2019 (COVID-19) at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy, complained of olfactory and taste disorders (OTDs), we performed a cross-sectional survey of the prevalence of these alterations in the context of SARS-CoV-2 infection. On 19 March 2020, a simple questionnaire including questions about the presence or absence of OTDs, their type and time of onset respective to hospitalization were submitted through verbal interview to all SARS-CoV-2–positive hospitalized patients who were able to give informed consent. Of 88 hospitalized patients, 59 were able to be interviewed (29 were nonrespondents, of whom 4 had dementia, 2 had a linguistic barrier, and 23 were on noninvasive ventilation) (Table 1). Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both. Twelve patients (20.3%) presented the symptoms before the hospital admission, whereas 8 (13.5%) experienced the symptoms during the hospital stay. Taste alterations were more frequently (91%) before hospitalization, whereas after hospitalization taste and olfactory alteration appeared with equal frequency. Females reported OTDs more frequently than males (10/19 [52.6%] vs 10/40 [25%]; P = .036). Moreover, patients with at least 1 OTD were younger than those without (median, 56 years [interquartile range {IQR}, 47–60] vs 66 [IQR, 52–77]; P = .035). All patients reported the persistence of OTDs at the time of the interview. Table 1. Characteristics of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Assessed for Taste and Olfactory Disorders (N = 59) Patients No. (%) Age, y, median (IQR) 60 (50–74) Male sex 40 (67.8) Days from illness onset to hospital admission, median (IQR) 6 (4–10) Days from illness onset to the interview, median (IQR) 15 (10–21) Pneumonia at hospital admission 43 (72.8) Symptoms at hospital admission  Fever 43 (72.8)  Cough 22 (37.3)  Dyspnea 15 (25.4)  Sore throat 1 (1.7)  Arthralgia 3 (5.1)  Coryza 1 (1.7)  Headache 2 (3.4)  Asthenia 1 (1.7)  Abdominal symptoms 5 (8.5) No taste or olfactory disorders 39 (66.1) With olfactory and/or taste disorders 20 (33.9) Taste disorders only  Dysgeusia 5 (8.5)  Ageusia 1 (1.7) Olfactory disorders only  Hyposmia 3 (5.1)  Anosmia 0 (0) Mixed taste and olfactory disorders  Dysgeusia and hyposmia 2 (3.4)  Dysgeusia and anosmia 2 (3.4)  Ageusia and hyposmia 2 (3.4)  Ageusia and anosmia 5 (8.5) Data are presented as no. (%) unless otherwise indicated. Abbreviations: IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Olfactory and taste disorders are well known to be related with a wide range of viral infections [4, 5]. SARS-CoV has demonstrated in a mice model a transneural penetration through the olfactory bulb [6]. Moreover, angiotensin-converting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7]. These findings could explain the underlying pathogenetic mechanism of taste and olfactory disorders in SARS-CoV-2 infection. Due to limitations related to the diffusivity of the disease and emergency contingencies, it was impossible to perform a more structured questionnaire associated with validated tests (ie, Pennsylvania smell identification test) [8]. However, our survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease. In a pandemic context, further investigations on nonhospitalized infected patients are required to ascertain if these symptoms, albeit unspecific, may represent a clinical screening tool to orientate testing of pauci-symptomatic individuals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Anosmia and Ageusia: Common Findings in COVID ‐19 Patients

            In a not negligible number of patients affected by COVID‐19 (coronavirus disease 2019), especially if paucisymptomatic, anosmia and ageusia can represent the first or only symptomatology present. Laryngoscope, 2020
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Presentation of New Onset Anosmia During the COVID-19 Pandemic

              Anosmia has not been formally recognised as a symptom of COVID-19 infection. Growing anecdotal evidence suggests increasing incidence of cases of anosmia during the current pandemic, suggesting that COVID-19 may cause olfactory dysfunction. The objective was to characterise patients reporting new onset anosmia during the COVID-19 pandemic METHODOLOGY: Design: Survey of 2428 patients reporting new onset anosmia during the COVID-19 pandemic.
                Bookmark

                Author and article information

                Contributors
                ian.wee@mohh.com.sg
                Journal
                Eur Arch Otorhinolaryngol
                Eur Arch Otorhinolaryngol
                European Archives of Oto-Rhino-Laryngology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0937-4477
                1434-4726
                24 April 2020
                : 1-2
                Affiliations
                [1 ]Singhealth Infectious Diseases Residency, Singapore, Singapore
                [2 ]GRID grid.163555.1, ISNI 0000 0000 9486 5048, Department of Infectious Diseases, , Singapore General Hospital, ; Singapore, Singapore
                [3 ]GRID grid.163555.1, ISNI 0000 0000 9486 5048, Department of Otolaryngology, , Singapore General Hospital, ; Singapore, Singapore
                Author information
                https://orcid.org/0000-0001-6428-9999
                Article
                5999
                10.1007/s00405-020-05999-5
                7180656
                32328771
                7781b1d5-f56b-42fb-ba7b-4fbed090f8f4
                © Springer-Verlag GmbH Germany, part of Springer Nature 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 14 April 2020
                : 18 April 2020
                Categories
                Letter to the Editor

                Otolaryngology
                anosmia,ageusia,covid-19
                Otolaryngology
                anosmia, ageusia, covid-19

                Comments

                Comment on this article